Sphingolipids in Asthma Pathogenesis

Peking University Third Hospital200 enrolled

Overview

The study aims to investigate the relationship between the small molecule metabolite sphingolipids and asthma clinical features and explore its involvement in asthma pathogenesis.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Asthma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. clinical diagnosis of asthma Exclusion Criteria: * 1\. Combined with chronic obstructive pulmonary disease, bronchiectasis, pneumonia, obstructive sleep apnea hypopnea syndrome, malignant tumor 2. Combined with acute and chronic respiratory failure 3. Combined with severe cardiovascular disease 4. Pregnant woman.

Locations (1)

Peking university third hospital

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

lipidomics

collect blood for lipidomic analysis and in vitro assays

Time frame: Day 1

Central Contacts

Chun Chang

CONTACT

15810075362 changc@bjmu.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.